India to United Kingdom: Pembrolizumab Export Trade Route
India has recorded 7 verified shipments of Pembrolizumab exported to United Kingdom, representing a combined trade value of $72.9K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $10.4K USD. The leading Indian exporter is GNH INDIA PHARMACEUTICALS LIMITED, which accounts for 97% of total export value with 2 shipments worth $71.0K USD. On the buying side, TO THE ORDER, is the largest importer in United Kingdom with $71.0K USD in purchases. The top 3 suppliers — GNH INDIA PHARMACEUTICALS LIMITED, LUPIN LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Pembrolizumab corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $72.9K USD. The route is dominated by GNH INDIA PHARMACEUTICALS LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's pembrolizumab manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $10.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 14.3%, placing it at rank #17 among India's top pembrolizumab export destinations globally.
On the import side, key buyers of Indian pembrolizumab in United Kingdom include TO THE ORDER,, TEST ARTICLE RECEIPT (TAR), TEST ARTICLE RECEIPT TAR and 2 others. TO THE ORDER, is the single largest importer with 2 shipments valued at $71.0K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#17
- Annual growth+14.3%
- Demand growth+14.3%
- Regulatory ease68/100
Top 10 Indian Pembrolizumab Exporters to United Kingdom
Showing top 10 of 3 Indian suppliers exporting Pembrolizumab to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GNH INDIA PHARMACEUTICALS LIMITED Avg $35.5K per shipment | 2 | $71.0K | 97.4% |
| 2 | LUPIN LIMITED Avg $937 per shipment | 2 | $1.9K | 2.6% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $12 per shipment | 3 | $35 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting pembrolizumab to United Kingdom, ranked by total trade value. The listed exporters are: GNH INDIA PHARMACEUTICALS LIMITED, LUPIN LIMITED, INTAS PHARMACEUTICALS LIMITED. GNH INDIA PHARMACEUTICALS LIMITED is the dominant supplier with 2 shipments worth $71.0K USD, giving it a 97% market share.
Top 10 Pembrolizumab Importers in United Kingdom
Showing top 10 of 5 known buyers in United Kingdom receiving Pembrolizumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pembrolizumab in United Kingdom include TO THE ORDER,, TEST ARTICLE RECEIPT (TAR), TEST ARTICLE RECEIPT TAR, SGS VITROLOGY, SGS VITROLOGY, FAO SAMPLE RECEIPT. The largest importer is TO THE ORDER,, accounting for $71.0K USD across 2 shipments — representing 97% of all pembrolizumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER, | 2 | $71.0K | 97.4% |
| 2 | TEST ARTICLE RECEIPT (TAR) | 1 | $940 | 1.3% |
| 3 | TEST ARTICLE RECEIPT TAR | 1 | $934 | 1.3% |
| 4 | SGS VITROLOGY | 1 | $19 | 0.0% |
| 5 | SGS VITROLOGY, FAO SAMPLE RECEIPT | 2 | $16 | 0.0% |
Top 10 Pembrolizumab Formulations Imported by United Kingdom
Showing top 10 of 6 product formulations shipped on the India to United Kingdom Pembrolizumab route, ranked by trade value
United Kingdom imports a wide range of pembrolizumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Keytruda 100mg/4ml Pembrolizumab/100mg/4 — accounts for $35.6K USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Keytruda 100mg/4ml Pembrolizumab/100mg/4 | 1 | $35.6K | 48.8% |
| 2 | KEYTRUDA 100MG/4ML PEMBROLIZUMAB/100MG/4 | 1 | $35.4K | 48.6% |
| 3 | PEMBROLIZUMAB MCB | 2 | $1.9K | 2.6% |
| 4 | PEMBROLIZUMAB MCB (P58), (BATCH NO:P58-MCB-0001)NOS | 1 | $19 | 0.0% |
| 5 | PEMBROLIZUMAB WCB (P58) (BATCH NO: P58-WCB-0001) Mfg. Date : NOV-24 & Exp. Date: N/A | 1 | $15 | 0.0% |
| 6 | PEMBROLIZUMAB P58_PLASMID MFG. DATE : JAN-24 & EXP. DATE : N/A | 1 | $1 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 2 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's pembrolizumab exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. GNH INDIA PHARMACEUTICALS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GNH INDIA PHARMACEUTICALS LIMITED, LUPIN LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $10.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as keytruda 100mg/4ml pembrolizumab/100mg/4 and pembrolizumab mcb, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER, is the largest importer with 2 shipments worth $71.0K USD — representing 97% of all pembrolizumab imports from India on this route.
Route Statistics
- Trade Volume
- $72.9K
- Avg. Shipment
- $10.4K
- Suppliers
- 3
- Buyers
- 5
- Transit (Sea)
- ~16 days
- Annual Growth
- +14.3%
Related Analysis
Reverse Direction
United Kingdom → India — Pembrolizumab (Import)Other Pembrolizumab Routes
Unlock the Full India to United Kingdom Pembrolizumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 7 shipments on this route.
Frequently Asked Questions — India to United Kingdom Pembrolizumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pembrolizumab to United Kingdom?
The leading Indian exporters of Pembrolizumab to United Kingdom are GNH INDIA PHARMACEUTICALS LIMITED, LUPIN LIMITED, INTAS PHARMACEUTICALS LIMITED. GNH INDIA PHARMACEUTICALS LIMITED holds the largest market share at approximately 97% of total trade value on this route.
Q What is the total value of Pembrolizumab exports from India to United Kingdom?
India exports Pembrolizumab to United Kingdom worth approximately $72.9K USD across 7 recorded shipments. The average value per shipment is $10.4K USD.
Q Which ports does India use to ship Pembrolizumab to United Kingdom?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 2 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United Kingdom for Pembrolizumab?
The average transit time for Pembrolizumab shipments from India to United Kingdom is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United Kingdom Pembrolizumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.3% with demand growth tracking at 14.3%. The route is ranked #17 among India's top Pembrolizumab export destinations globally.
Q How many suppliers are active on the India to United Kingdom Pembrolizumab route?
There are currently 3 active Indian suppliers exporting Pembrolizumab to United Kingdom. The market is moderately concentrated with GNH INDIA PHARMACEUTICALS LIMITED accounting for 97% of total shipment value.
Q Who are the main importers of Pembrolizumab from India in United Kingdom?
The leading importers of Indian Pembrolizumab in United Kingdom include TO THE ORDER,, TEST ARTICLE RECEIPT (TAR), TEST ARTICLE RECEIPT TAR, SGS VITROLOGY, SGS VITROLOGY, FAO SAMPLE RECEIPT. TO THE ORDER, is the largest buyer with 2 shipments worth $71.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Pembrolizumab.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 5 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 7 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists